EWNYSESEC EDGAREDGAR

Edwards Lifesciences Corp

Orthopedic, Prosthetic & Surgical Appliances & Supplies·IRVINE, CA·FY end 12/31·CIK 1099800

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Mr. ZovighianChief Executive Officer and Director
$1.2M$7.2M$6.5M$2.4M$189.1K$17.5M
Mr. UllemCorporate Vice President, Chief Financial Officer
$807.9K$2.2M$2.0M$966.4K$71.3K$6.1M
Mr. WoodFormer Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart
$635.9K$1.8M$1.6M$689.4K$61.8K$4.9M
Mr. ChopraCorporate Vice President, Transcatheter Mitral and Tricuspid Therapies
$671.0K$1.8M$1.4M$824.2K$60.6K$4.7M
Mr. BoboCorporate Vice President, Strategy & Corporate Development
$759.8K$1.4M$1.2M$786.9K$48.6K$4.2M
Ms. Brüls
$726.6K$1.0M$925.0K$719.6K$340.6K$3.7M

CEO pay mix

Mr. Zovighian · FY 2025
Total$17.5M
Stock awards$7.2M41%
Performance bonus$2.4M14%
Salary$1.2M7%
Other$6.7M38%

Performance vs. pay

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure
FY
TSR
CEO comp
FY21
+42%
$32M
FY22
-18%
$-11M
FY23
-16%
$11M
FY24
-19%
$9M
FY25
-7%
$21M

CEO comp · median worker · ratio — multi-year trend

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.